Usha Sundralingam Selected Research

4,17 beta-dihydroxy-4-androstene-3-one

8/2020	Efficacy of Emu Oil Transfersomes for Local Transdermal Delivery of 4-OH Tamoxifen in the Treatment of Breast Cancer.
5/2019	Review: Patient-controlled transdermal 4-hydroxytamoxifen (4-OHT) vs. oral tamoxifen: A systematic review and meta analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Usha Sundralingam Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 09/2021 - 05/2019
2	Neoplasms (Cancer) 09/2021 - 08/2020
2	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2020 - 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 12/2022
1	Obesity 02/2021
1	Necrosis 08/2020

Drug/Important Bio-Agent (IBA)

2	afimoxifene (hydroxytamoxifen)IBA 09/2021 - 05/2019
2	Tamoxifen FDA LinkGeneric 08/2020 - 05/2019
2	4,17 beta-dihydroxy-4-androstene-3-oneIBA 08/2020 - 05/2019
1	DiterpenesIBA 12/2022
1	labdaneIBA 12/2022
1	PolyphenolsIBA 02/2021
1	PrebioticsIBA 02/2021
1	Estrogens (Estrogen)FDA Link 08/2020
1	emu OilIBA 08/2020

Therapy/Procedure

1	Cutaneous Administration 05/2019
1	Therapeutics 05/2019